1. Home
  2. BCH vs SNN Comparison

BCH vs SNN Comparison

Compare BCH & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCH

Banco De Chile ADS

HOLD

Current Price

$44.96

Market Cap

22.3B

Sector

Finance

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$35.46

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCH
SNN
Founded
1893
1856
Country
Chile
United Kingdom
Employees
N/A
N/A
Industry
Commercial Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3B
14.3B
IPO Year
2002
1999

Fundamental Metrics

Financial Performance
Metric
BCH
SNN
Price
$44.96
$35.46
Analyst Decision
Hold
Hold
Analyst Count
1
4
Target Price
$36.00
$32.83
AVG Volume (30 Days)
450.6K
1.1M
Earning Date
02-03-2026
03-02-2026
Dividend Yield
3.50%
2.07%
EPS Growth
N/A
59.91
EPS
0.01
0.56
Revenue
$2,935,400,013.00
$5,944,000,000.00
Revenue This Year
$26.08
$7.71
Revenue Next Year
$6.51
$5.23
P/E Ratio
$17.15
$63.39
Revenue Growth
N/A
5.35
52 Week Low
$23.66
$23.91
52 Week High
$46.77
$38.79

Technical Indicators

Market Signals
Indicator
BCH
SNN
Relative Strength Index (RSI) 61.80 62.82
Support Level $43.83 $34.20
Resistance Level $45.61 $35.35
Average True Range (ATR) 1.23 0.61
MACD -0.08 0.19
Stochastic Oscillator 67.58 98.44

Price Performance

Historical Comparison
BCH
SNN

About BCH Banco De Chile ADS

Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: